AbstractBackground and purposeWe try to search for specific serum or urinary biomarkers for the early detection, follow-up, and prediction of tumor recurrence, progression, and clinical outcome is a difficult task in individuals with bladder cancer.Materials and methodsIn this study, urinary samples were dialyzed to remove any interfering molecules and concentration by lyophilization. The urinary proteome maps of 10 healthy volunteers and 10 bladder transitional cell carcinoma (BTTC) patients were explored through two-dimensional polyacrylamide gel electrophoresis (2-D PAGE) coupled with mass spectrometry. With no fractionation, the proteome maps acquired in this study likely represented the total urinary proteins.ResultsComparative proteom...
To identify aggressiveness-associated molecular mechanisms and biomarker candidates in bladder cance...
Secreted proteins play a key role in cell signaling, communication and migration. We recently descri...
<p>(<b>A</b>) Digitalized proteomic profile of bladder cancer development from <i>in situ</i> neopla...
AbstractBackground and purposeWe try to search for specific serum or urinary biomarkers for the earl...
Background: Proteomic discovery of cancer biomarkers in body fluids is challenging because of their...
<p>The proteomic profile of bladder cancer development from <i>in situ</i> neoplasia was developed o...
Urinary bladder cancer is a heterogeneous disease appearing in different forms, e.g. non-muscle inva...
AbstractIn this study, we evaluated the reproducibility of abundant urine protein depletion by hexap...
Bladder cancer (BC) is the most common tumor of the urinary tract and is conventionally classified a...
Background: Proteomic discovery of cancer biomarkers in body fluids is challenging because of their ...
Developing a urine test to detect bladder tumours with high sensitivity and specificity is a key goa...
We used protein expression profiles to develop a classification rule for the detection and prognosti...
Bladder cancer is the 10th most common cancer in the world [1]. It is the 6th most common amongst me...
Background: Bladder cancer is a life-threatening disease and a major cause of cancer-associated comp...
Background. Though there are several prognostic models, there is no protein-related prognostic model...
To identify aggressiveness-associated molecular mechanisms and biomarker candidates in bladder cance...
Secreted proteins play a key role in cell signaling, communication and migration. We recently descri...
<p>(<b>A</b>) Digitalized proteomic profile of bladder cancer development from <i>in situ</i> neopla...
AbstractBackground and purposeWe try to search for specific serum or urinary biomarkers for the earl...
Background: Proteomic discovery of cancer biomarkers in body fluids is challenging because of their...
<p>The proteomic profile of bladder cancer development from <i>in situ</i> neoplasia was developed o...
Urinary bladder cancer is a heterogeneous disease appearing in different forms, e.g. non-muscle inva...
AbstractIn this study, we evaluated the reproducibility of abundant urine protein depletion by hexap...
Bladder cancer (BC) is the most common tumor of the urinary tract and is conventionally classified a...
Background: Proteomic discovery of cancer biomarkers in body fluids is challenging because of their ...
Developing a urine test to detect bladder tumours with high sensitivity and specificity is a key goa...
We used protein expression profiles to develop a classification rule for the detection and prognosti...
Bladder cancer is the 10th most common cancer in the world [1]. It is the 6th most common amongst me...
Background: Bladder cancer is a life-threatening disease and a major cause of cancer-associated comp...
Background. Though there are several prognostic models, there is no protein-related prognostic model...
To identify aggressiveness-associated molecular mechanisms and biomarker candidates in bladder cance...
Secreted proteins play a key role in cell signaling, communication and migration. We recently descri...
<p>(<b>A</b>) Digitalized proteomic profile of bladder cancer development from <i>in situ</i> neopla...